Bacterial-directed enzyme prodrug therapy
- PMID: 23688772
- DOI: 10.1016/j.jconrel.2013.05.005
Bacterial-directed enzyme prodrug therapy
Abstract
Current conventional treatments for cancer lack tumour selectivity resulting in the destruction of healthy tissue and severe adverse effects to the patient in addition to limiting the administration dose and efficacy. Hence, it is imperative that we seek alternative approaches to treat cancer that localise therapeutic agents to the site of the tumour and spare normal tissue. The use of bacteria in cancer therapy represents one such approach. Bacteria were first used as anti-cancer agents over a century ago. Today, this field has re-emerged from the past and is progressing at a rapid rate. Bacteria are used as anticancer agents either alone or in combination with conventional treatments and have been armed with an arsenal of therapeutic genes, which enhance their efficacy. Bacterial directed enzyme prodrug therapy (BDEPT) is one of the most promising approaches, which harnesses the tumour-specific location of bacteria to locally activate systemically administered 'prodrugs' within the tumour in order to induce selective tumour destruction. BDEPT is a relatively new concept. It was originally conceived more than 10years ago but it is only until recently that we witness a surge in activity in this field. In this review, we provide a full account of developments in the field of BDEPT since its inception. We share technical knowhow and discuss optimization strategies for vector and enzyme combinations, provide a clear view of the research landscape and suggest possible directions for the field.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Designer bacteria as intratumoural enzyme biofactories.Adv Drug Deliv Rev. 2017 Sep 1;118:8-23. doi: 10.1016/j.addr.2017.09.012. Epub 2017 Sep 12. Adv Drug Deliv Rev. 2017. PMID: 28916496 Review.
-
Advances in imaging gene-directed enzyme prodrug therapy.Curr Pharm Biotechnol. 2011 Apr;12(4):497-507. doi: 10.2174/138920111795163896. Curr Pharm Biotechnol. 2011. PMID: 21342105 Review.
-
Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy.Biochem Pharmacol. 2018 Dec;158:192-200. doi: 10.1016/j.bcp.2018.10.020. Epub 2018 Oct 21. Biochem Pharmacol. 2018. PMID: 30352235
-
Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.J Control Release. 2015 Feb 28;200:179-87. doi: 10.1016/j.jconrel.2015.01.003. Epub 2015 Jan 7. J Control Release. 2015. PMID: 25575867 Free PMC article.
-
Viral vectors for gene-directed enzyme prodrug therapy.Curr Gene Ther. 2006 Dec;6(6):647-70. doi: 10.2174/156652306779010679. Curr Gene Ther. 2006. PMID: 17168697 Review.
Cited by
-
Promising dawn in tumor microenvironment therapy: engineering oral bacteria.Int J Oral Sci. 2024 Mar 13;16(1):24. doi: 10.1038/s41368-024-00282-3. Int J Oral Sci. 2024. PMID: 38472176 Free PMC article. Review.
-
Staphopain mediated virulence and antibiotic resistance alteration in co-infection of Staphylococcus aureus and Pseudomonas aeruginosa: an animal model.BMC Biotechnol. 2024 Mar 4;24(1):10. doi: 10.1186/s12896-024-00840-x. BMC Biotechnol. 2024. PMID: 38439037 Free PMC article.
-
Bacterial-Mediated Tumor Therapy: Old Treatment in a New Context.Adv Sci (Weinh). 2023 Apr;10(12):e2205641. doi: 10.1002/advs.202205641. Epub 2023 Mar 12. Adv Sci (Weinh). 2023. PMID: 36908053 Free PMC article. Review.
-
Structural insights into catalytical capability for CPT11 hydrolysis and substrate specificity of a novel marine microbial carboxylesterase, E93.Front Microbiol. 2023 Jan 11;13:1081094. doi: 10.3389/fmicb.2022.1081094. eCollection 2022. Front Microbiol. 2023. PMID: 36756200 Free PMC article.
-
A rapid screening platform to coculture bacteria within tumor spheroids.Nat Protoc. 2022 Oct;17(10):2216-2239. doi: 10.1038/s41596-022-00723-5. Epub 2022 Jul 29. Nat Protoc. 2022. PMID: 35906291 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous